An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer.

[1]  Y. Erdi,et al.  FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection , 2001, European Journal of Nuclear Medicine.

[2]  R. Rami-Porta,et al.  Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. , 2000, The Annals of thoracic surgery.

[3]  R L Wahl,et al.  Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.

[4]  S. Larson,et al.  Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. , 1999, American journal of surgery.

[5]  J. Padilla,et al.  Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. , 1999, Lung cancer.

[6]  S. Berlangieri,et al.  F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  T. Olencki,et al.  Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer. , 1999, American journal of clinical oncology.

[8]  P. Dupont,et al.  Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  P. V. Van Schil,et al.  Repeat mediastinoscopy in the staging of lung cancer. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  J. Roth,et al.  Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1998, Lung cancer.

[11]  J Bogaert,et al.  Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[13]  D. Sugarbaker,et al.  Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). , 1997, Lung cancer.

[14]  G. V. von Schulthess,et al.  Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.

[15]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[16]  M. Kris,et al.  Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Kris,et al.  Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. , 1993, The Annals of thoracic surgery.

[18]  M. Kris,et al.  The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0). , 1988, The Annals of thoracic surgery.

[19]  K. S. Lee,et al.  Primary tumors and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: serial CT findings with pathologic correlation. , 2000, Journal of computer assisted tomography.